Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasensitive Biosensor Detects Cancer

By LabMedica International staff writers
Posted on 04 Jun 2012
An ultrasensitive biosensor has been created that could open up new opportunities for early detection of cancer and personalized medicine tailored to the specific biochemistry of individual patients. More...


The device, which could be several hundred times more sensitive than other biosensors, combines the attributes of two distinctly different types of sensors, a mechanical sensor, which identifies a biomolecule based on its mass or size, and an electrical sensor that identifies molecules based on their electrical charge.

At Purdue University (West Lafayette, IN, USA) scientists found that the new sensor detects both charged and uncharged biomolecules, allowing a broader range of applications than either type of sensor alone. The sensor's mechanical part is a vibrating cantilever, a sliver of silicon that resembles a tiny diving board. Located under the cantilever is a transistor, which is the sensor's electrical part. The sensor maximizes sensitivity by putting both the cantilever and transistor in a "bias.” The cantilever is biased using an electric field to pull it downward as though with an invisible string.

In other mechanical biosensors, a laser measures the vibrating frequency or deflection of the cantilever, which changes depending on what type of biomolecule lands on the cantilever. Instead of using a laser, the new sensor uses the transistor to measure the vibration or deflection. In early cancer diagnostics, the sensor makes possible the detection of small quantities of DNA fragments and proteins deformed by cancer long before the disease is visible through imaging or other methods. The device is called a Flexure-field effect transistor (FET) biosensor. A key innovation is the elimination of a component called a reference electrode, which is required for conventional electrical biosensors, but cannot be miniaturized, limiting practical applications.

The authors concluded that there are broad ranges of applications that can benefit from the sensitivity gain of the biosensor. For example, the current genome sequencing schemes require polymerase chain reaction (PCR) amplification of DNA strands because of the lower sensitivity of existing biosensors. The high sensitivity of Flexure-FET can eliminate the requirement of multiplication step and hence reduce the cost of sequencing. The study was published on May 23 2012, in the Proceedings of the National Academy of Sciences of the United States of America.

Related Links:

Purdue University



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.